ATX, LPAR1 and LPAR2 are overexpressed in different tumor types, including ovarian cancer, osteocarcinoma, metastatic melanoma, neuroblastoma, breast cancer, pancreatic cancer, prostate cancer, and hepatocellular carcinoma [43,60]. This evidence concerns the gene LPAR1 and breast carcinoma.